IRulya Therapeutics Inc 10-Q for FY2026 Q2
IRulya Therapeutics Inc. (IRLA)
10-Q
2026-08-14
For: 2026-06-30
View Original
Added on
August 14, 2026
About this 10-Q
IRulya Therapeutics Inc filed this 10-Q on August 14, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $75.49M
- compared with a net loss of $16.05M a year earlier
- Diluted EPS
- -$12.31
- compared with -$68.75 a year earlier